Monoclonal Antibody to Fungal Glucosylceramide Protects Mice against LethalCryptococcus neoformansInfection

Abstract
Glucosylceramides (GlcCer) are involved in the regulation of Cryptococcus neoformans virulence. In the present study, we demonstrate that passive immunization with a monoclonal antibody to GlcCer significantly reduces host inflammation and prolongs the survival of mice lethally infected with C. neoformans, revealing a potential therapeutic strategy to control cryptococcosis.

This publication has 45 references indexed in Scilit: